11.07.19-016-2038110808-2025 : 865,6
It covers three agents: liraglutide, semaglutide, and tirzepatide
Per a March 3, 2026 FDA press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products, including claims that implied sameness with FDA-approved medications
Individuals taking Mounjaro, particularly for weight management, may be at increased risk of developing nutritional deficiencies if their diet becomes significantly restricted or unbalanced
Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy
Work with both your surgical team and PlexusDx to time your restart